We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Chinese Drug Company Sued Over Valsartan With Potential Carcinogen

Mealey's (August 24, 2018, 9:09 AM EDT) -- NEW YORK — A class action was filed Aug. 16 in New York federal court against the manufacturers and retailers of a blood pressure/heart failure drug that allegedly contains a potential...
To view the full article, register now.